Manager, IT Business Analysis – R&D IT Research Business Systems

Foster City, California, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a deep understanding of pharmaceutical research and development, along with keen insight into technological trends such as cloud computing, Agile methodologies, data analytics, and AI/ML. Exceptional analytical and critical thinking skills are essential for use case analysis, functional design specification, and process mapping. The role requires the ability to orchestrate IT resource allocation and coordination to meet project timelines and business goals.

Responsibilities

The Manager, IT Business Analysis will lead the evaluation, analysis, and planning of technology and process needs to support business strategies and operations. Responsibilities include acting as the lead business analyst for assigned business groups or IT domains, participating in feasibility analysis for new systems, and conducting post-implementation reviews to assess solution effectiveness. This role also involves monitoring operations for optimization opportunities, leading continuous improvement efforts, and coordinating internal and external IT resources for assigned projects.

Skills

Business Analysis

IT Business Analysis

Technology Solutions

Business Strategies

Operational Efficiency

Strategic Goals

Process Analysis

Planning

Collaboration

R&D IT

Research Business Systems

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free